Novel NF-kappa B Inhibitor Alpha Gain-of-Function Variant in an Infant with Lymphocytosis and Recurrent Serratia Bacteremia

J Clin Immunol. 2023 Aug;43(6):1122-1126. doi: 10.1007/s10875-023-01481-z. Epub 2023 Apr 10.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Bacteremia* / diagnosis
  • Bacteremia* / drug therapy
  • Gain of Function Mutation
  • Humans
  • Infant
  • Lymphocytosis* / diagnosis
  • Lymphocytosis* / genetics
  • NF-KappaB Inhibitor alpha
  • NF-kappa B
  • Serratia
  • Tumor Necrosis Factor-alpha

Substances

  • NF-kappa B
  • NF-KappaB Inhibitor alpha
  • Tumor Necrosis Factor-alpha